Stock Analysis on Net
Stock Analysis on Net

AstraZeneca PLC (NYSE:AZN)

This company has been moved to the archive! The financial data has not been updated since March 10, 2015.

Common-Size Balance Sheet: Assets

AstraZeneca PLC, common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Property, plant and equipment 10.26 10.41 11.37 12.16 12.40
Goodwill 19.71 17.86 18.49 18.67 17.59
Intangible assets 35.81 28.71 30.72 20.78 21.66
Investments in joint ventures 0.10 0.00 0.00 0.00 0.00
Other investments 0.86 0.50 0.37 0.38 0.38
Derivative financial instruments 0.79 0.65 0.73 0.65 0.58
Other receivables 1.90 3.34 0.66 0.00 0.00
Deferred tax assets 2.08 2.16 2.08 2.87 2.63
Non-current assets 71.50% 63.62% 64.42% 55.51% 55.22%
Inventories 3.34 3.42 3.85 3.51 3.00
Trade receivables, less amounts provided for doubtful debts 8.13 9.86 10.64 12.55 11.13
Other receivables 1.83 1.42 1.56 2.34 1.20
Prepayments and accrued income 2.39 2.81 2.05 1.68 1.66
Trade and other receivables 12.34% 14.10% 14.25% 16.57% 13.98%
Other investments 1.36 1.42 1.54 8.04 2.64
Derivative financial instruments 0.04 0.07 0.06 0.05 0.02
Income tax receivable 0.56 0.88 1.50 2.00 5.42
Cash and cash equivalents 10.85 16.49 14.39 14.33 19.72
Current assets 28.50% 36.38% 35.58% 44.49% 44.78%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Balance sheet item Description The company
Property, plant and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. AstraZeneca PLC property, plant and equipment as a percentage of total assets decreased from 2012 to 2013 and from 2013 to 2014.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. AstraZeneca PLC non-current assets as a percentage of total assets decreased from 2012 to 2013 but then increased from 2013 to 2014 exceeding 2012 level.
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. AstraZeneca PLC current assets as a percentage of total assets increased from 2012 to 2013 but then decreased significantly from 2013 to 2014.